Interleukin-1#, Human, Recom 1PC X 2UG

Code: 407611-2ug D2-231

Not available outside of the UK & Ireland.

Biochem/physiol Actions

ED50 = 3-7 pg/ml as measured in a cell proliferation assay.

General description

Recombinant, human ...


read more

Your Price
£345.00 EACH

Not available outside of the UK & Ireland.

Biochem/physiol Actions

ED50 = 3-7 pg/ml as measured in a cell proliferation assay.

General description

Recombinant, human interleukin-1α expressed in E. coli. Potent stimulator of bone resorption and stimulator of nuclear phospholipase C. Induces nitric oxide synthase.

Recombinant, human interleukin-1α expressed in E. coli. A 159 amino acid polypeptide derived from mature IL-1α. Synthesized in vivo as a 271 amino acid residue (31 kDa) precursor that is subsequently cleaved into the mature polypeptide. Shows ~25% amino acid sequence identity with IL-1β, a distinct gene product sharing the same cell surface receptors as IL-1α. Produced by activated macrophages and many other cell types, the IL-1 proteins mediate a variety of effects on the differentiation and function of many cell types involved in inflammatory and immune responses. Potent stimulator of bone resorption and stimulator of nuclear phospholipase C. Induces nitric oxide synthase. Effects include stimulation of T-cell, B-cell, neutrophil, and fibroblast proliferation; induction of prostaglandin, leukotriene, and acute-phase hepatic protein synthesis; induction of proteinases in synovial fibroblasts and articular chondrocytes. IL-1 is also known to induce fever, slow-wave sleep, and bone resorption. 1 µg is equivalent to 1.6 x 105 WHO units.

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Other Notes

Tsan, M.F., and White, J.E. 1994. Am. J. Physiol. 266, L316.Kilbourn, R.G., et al. 1992. J. Natl. Cancer Inst. 84, 1008.Dinarello, C.A., et al. 1991. Blood77, 1627.Casagli, M.C., et al. 1989. Biochem. Biophys. Res. Commun.162, 357.Symons, J.A., et al. 1987. In Lymphokines and Interferons, A Practical Approach (Clemens, M.J., et al. Eds.) Oxford IRL Press, p. 272.March, C.J., et al. 1985. Nature315, 641.Kampschmidt, R.F. 1984. J. Leuk. Biol.36, 341.

Packaging

2 µg in Plastic ampoule

Physical form

Lyophilized from sterile-filtered 20 mM Tris-HCl, 50 µg BSA/µg IL-1α, pH 8.3.

Reconstitution

Following reconstitution, aliquot and freeze (-70°C) for long term storage or refrigerate (4°C) for short term storage. Avoid freeze/thaw cycles of solutions. Stock solutions are stable for up to 1 month at 4°C or for up to 3 months at -70°C.

Reconstitute with sterile PBS containing ≥0.1% HSA or BSA.

Warning

Toxicity: Standard Handling (A)

assay≥97% (SDS-PAGE)
formlyophilized
impurities≤1.0 EU/µg Endotoxin (EU/µg IL-1α)
manufacturer/tradenameCalbiochem®
Quality Level100
shipped inambient
storage conditionOK to freeze
storage temp.−70°C
This product has met the following criteria: